share_log

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wubin Pan(12.1%),BioFortune Inc(11.2%)

SEC announcement ·  Feb 13 16:32
Summary by Moomoo AI
Connect Biopharma Holdings Limited, a biopharmaceutical company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 13, 2024, indicating changes in ownership by significant shareholders. The filing reveals that BioFortune Inc., based in the British Virgin Islands, and Wubin Pan, a Canadian citizen, have reported beneficial ownership of the company's ordinary shares. As of December 31, 2023, BioFortune Inc. owns 6,158,016 ordinary shares, representing 11.2% of the class, while Wubin Pan has a beneficial ownership of 6,728,292 ordinary shares, or 12.1% of the class. The ownership includes shares held directly by BioFortune Inc., shares underlying stock options held by Pan that are exercisable as of March 1, 2024, and shares held by Pan's spouse. Wubin Pan, who is the sole shareholder of BioFortune Inc., may be deemed to share beneficial ownership of the securities held by BioFortune Inc. The total number of ordinary shares outstanding for Connect Biopharma as of the reporting date was 55,102,954.
Connect Biopharma Holdings Limited, a biopharmaceutical company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 13, 2024, indicating changes in ownership by significant shareholders. The filing reveals that BioFortune Inc., based in the British Virgin Islands, and Wubin Pan, a Canadian citizen, have reported beneficial ownership of the company's ordinary shares. As of December 31, 2023, BioFortune Inc. owns 6,158,016 ordinary shares, representing 11.2% of the class, while Wubin Pan has a beneficial ownership of 6,728,292 ordinary shares, or 12.1% of the class. The ownership includes shares held directly by BioFortune Inc., shares underlying stock options held by Pan that are exercisable as of March 1, 2024, and shares held by Pan's spouse. Wubin Pan, who is the sole shareholder of BioFortune Inc., may be deemed to share beneficial ownership of the securities held by BioFortune Inc. The total number of ordinary shares outstanding for Connect Biopharma as of the reporting date was 55,102,954.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more